A nationwide survey finds variability in rare cancer care organization and proposes improvements for better outcomes.
national vs. regional level, and according to the roles and types of participating hospitals and multidisciplinary teams.Interviews identified preconditions for strengthening rare cancer care organisation, including adequate financing and medical collaboration (e.g.promoting clinical research).Conclusions: Organisation of rare cancer care in the Netherlands varies substantially across cancer types.This heterogeneity indicates a need for more structured organisation of expertise, clearer and more consistent agreements, and cross-learning from good practice examples.
No takes yet. Share an insight, caveat, or question.
Yasar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: